News tagged with cannabinoid
In a first-of-its-kind effort to illuminate the biochemical impact of trauma, researchers at NYU Langone Medical Center have discovered a connection between the quantity of cannabinoid receptors in the human brain, known ...
Psychology & Psychiatry May 14, 2013 | not rated yet | 0
Researchers at the University of the Basque Country (UPV/EHU) and the Achucarro neurosciences centre have discovered a new therapy for the fragile X chromosome syndrome. This new therapy proposes the modulation of the cerebral ...
Medical research Apr 10, 2013 | 5 / 5 (1) | 0
(HealthDay)—U.S emergency rooms tended to more than 11,400 cases of drug-related health complications specifically linked to the use of synthetic marijuana in 2010, a new government report reveals.
Addiction Dec 04, 2012 | not rated yet | 1
Research led by Chu Chen, PhD, Associate Professor of Neuroscience at LSU Health Sciences Center New Orleans, has identified an enzyme called Monoacylglycerol lipase (MAGL) as a new therapeutic target to treat or prevent ...
Alzheimer's disease & dementia Nov 01, 2012 | 5 / 5 (2) | 0 |
A study from the University of Calgary's Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enrolled 60 patients with diabetic ...
Diabetes Oct 30, 2012 | not rated yet | 0 |
Nonprescription medications are just as likely a cause of poisoning as prescription drugs, according to a new study by Timothy Wiegand, M.D. from the University of Rochester Medical Center in the US and colleagues. Their ...
Medications Oct 04, 2012 | not rated yet | 0
(Medical Xpress)—Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous ...
Cancer Sep 26, 2012 | not rated yet | 0
Washington State University researchers have found a cellular mechanism that contributes to the lack of motivation and negative emotions of a cocaine addict going through withdrawal. Their discovery, published in the latest ...
Medical research Sep 10, 2012 | 3 / 5 (2) | 1
A compound developed to treat neuropathic pain has shown potential as an innovative treatment for Alzheimer's disease, according to a study by researchers at Cleveland Clinic's Lerner Research Institute and Anesthesiology ...
Alzheimer's disease & dementia Aug 31, 2012 | not rated yet | 0
A new drug could aid in losing weight and keeping it off. The drug, described in the journal Cell Metabolism on July 26, increases sensitivity to the hormone leptin, a natural appetite suppressant found in the body. Althou ...
Medical research Jul 26, 2012 | 5 / 5 (1) | 1 |
(HealthDay) -- About 10 percent of fibromyalgia patients use marijuana to relieve symptoms such as pain, fatigue and insomnia, a new study has found.
Arthritis & Rheumatism Jun 22, 2012 | not rated yet | 3
(Medical Xpress) -- No drug treatments exist to treat sleep apnea, a disorder that affects more than 18 million Americans. Researchers at the University of Illinois at Chicago College of Nursing are working to change that. ...
Sleep apnea Jun 21, 2012 | 5 / 5 (1) | 0
Mothers who use marijuana as teenslong before having childrenmay put their future children at a higher risk of drug abuse, new research suggests.
Addiction Jun 05, 2012 | not rated yet | 0
A new study lead by the Neuroscience Institute of Alicante reveals how manipulating the endocannabinoid system can modulate high levels of impulsivity. This is the main problem in psychiatric illnesses such ...
Psychology & Psychiatry Mar 08, 2012 | 4 / 5 (4) | 0
A type of fake pot has raised new health concerns in the United States after at least three users were hospitalized for kidney failure, authorities in the western state of Wyoming said Monday.
Medications Mar 05, 2012 | not rated yet | 0
Cannabinoids are a class of chemical compounds which include the phytocannabinoids (oxygen-containing C21 aromatic hydrocarbon compounds found in the cannabis plant), and chemical compounds which mimic the actions of phytocannabinoids or have a similar structure (e.g. endocannabinoids, found in the nervous and immune systems of animals and that activate cannabinoid receptors). The most notable of the cannabinoids is ∆9-tetrahydrocannabinol (THC)—the primary psychoactive compound of cannabis.
Synthetic cannabinoids encompass a variety of distinct chemical classes: the classical cannabinoids structurally related to THC, the nonclassical cannabinoids including the aminoalkylindoles, 1,5-diarylpyrazoles, quinolines and arylsulphonamides, as well as eicosanoids related to the endocannabinoids.
For more information about Cannabinoid, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.